Chen Cao

Title: Chen Cao: Pharmaceutical Innovation in Cataract Treatment

Introduction

Chen Cao is an inventor based in Guangzhou, China. His patent work includes a pharmaceutical composition intended for the prevention or treatment of cataracts.

Latest Patents

Cao is associated with 1 patent: “Pharmaceutical Composition, Preparation Method Therefor and Application Thereof.” The invention describes a composition containing a compound represented by Formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. It also outlines a preparation method and potential applications in medicines for preventing or treating cataracts.

The patent describes the composition as stable under light exposure and high temperatures, suitable for room-temperature storage, and convenient for patients to use. Its pH and osmotic pressure are designed to be close to those of the intraocular environment, while its uniform particle-size distribution is intended to support patient comfort.

Career Highlights

Cao’s listed company affiliations include Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. His patent work reflects a focus on ophthalmic pharmaceutical development.

Collaborations

Cao’s listed coworkers include Yandong Wang and Yingxue Su.

Conclusion

Chen Cao’s patent centers on a cataract-related pharmaceutical composition designed for stability, practical storage, and patient comfort. His work and company affiliations connect him with ophthalmic biotechnology and pharmaceutical development in Guangzhou.